To Evaluate the Efficacy of Sugammadex in Reversing the effect of a Muscle Relaxant in Patients Undergoing Major Upper Abdominal Surgery: An Observational Study
- Conditions
- Medical and Surgical,
- Registration Number
- CTRI/2023/07/055172
- Lead Sponsor
- Dr. Ram Manohar Lohia Institute of Medical Sciences
- Brief Summary
During general anesthesia muscle relaxants are given to faciliotate endotracheal intubation and for optimum surgical conditions. A complication may be post operative residual blockade during a prolonged surgical procedure. Intraoperatively Neuromuscular monitoring can be used to allow proper administration of the relaxant to decrease the incidence of post operative residual curarization. After the completion of the surgery we use a reversal agent as in this case, Sugammadex which has showed decreased incidence of the post operative complications related to residual blockade. Diaphragm Ultrasound (Thickening fractioning) and Neuromuscular monitoring (Train of Four ratio) will be the primary modalities we use to evaluate the efficacy of Sugammadex against the traditionally used reversal Neostigmine.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- All
- Target Recruitment
- 50
ASA 1 and 2 Patients posted for major upper abdominal surgery.
Refusal to consent ASA 3, 4 and Emergency cases Patients with preoperative respiratory involvement BMI >30.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To determine the time from administration of Sugammadex till extubation on the basis of Train of Four ratio 0.9 After administration of Reversal agent
- Secondary Outcome Measures
Name Time Method To detremine the risk of post operative residual paralysis using diaphragm ultrasound Preoperative baseline
Trial Locations
- Locations (1)
Dr. Ram Manohar Lohia Institute of Medical Sciences
🇮🇳Lucknow, UTTAR PRADESH, India
Dr. Ram Manohar Lohia Institute of Medical Sciences🇮🇳Lucknow, UTTAR PRADESH, IndiaDr Shilpi MisraPrincipal investigator9839932239drshilpi1980@gmail.com